Translate
Back to AI News
Ars Technica AI

OpenEvidence hits $15B valuation as AI medical search spreads among US doctors

OpenEvidence, a Miami-based startup founded by Daniel Nadler in 2022, has reached a $15 billion valuation with an ad-powered AI search engine used by nearly two-thirds of US doctors, according to the report. The company says physicians processed more than 42 million prompts last month while using the chatbot to search medical journals and clinical guidelines for diagnosis and treatment decisions. The platform's adoption has prompted debate over the future of patient care.

AI Brief

It documents a concrete, rapidly growing commercial AI product with substantial adoption inside clinical decision-making and a notable valuation milestone.

Nearly two-thirds of US doctors are turning to an AI-powered search engine to make patient decisions, pRoPElling a little-known tech startup to a $15 billion valuation while prompting a debate over the future of patient care.

Miami-based OpenEvidence, founded by serial entrepreneur Daniel Nadler in 2022, said that many of America’s 1 million physicians processed more than 42 million prompts last month. Doctors are using the company’s chatbot to scour medical journals and clinical guidelines to help diagnose and treat patients.

The ads-powered platfORM has grown largely by word of mouth, penetrating a SECtor where few tools have seen similar trACTion. “We’re the first viral consumer internet APP in healthcare,” Nadler told the FT in an interview.

Read full article

Comments

openevidencelist-1152x648.jpg
Be the first to rate this article.

Comments & Questions (0)

Captcha
Please be respectful — let's keep the conversation friendly.

No comments yet

Be the first to comment!